T Takashima Selected Research

T Takashima Research Topics

Disease

11	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2000
6	Neoplasms (Cancer) 01/2019 - 05/2000
3	Infections 07/2003 - 07/2000
2	Lymphatic Metastasis 07/2010 - 08/2001
2	Dyspepsia (Indigestion) 06/2005 - 01/2004
2	Gastritis 01/2004 - 07/2003
2	Carcinoma (Carcinomatosis) 09/2001 - 01/2001
1	Circulating Neoplastic Cells 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2016
1	Fibrosis (Cirrhosis) 12/2016
1	Chronic Hepatitis C 12/2016
1	Chronic Hepatitis B 12/2016
1	Triple Negative Breast Neoplasms 07/2010
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 11/2008
1	Extensively Drug-Resistant Tuberculosis 11/2008
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2006
1	Anaplastic Thyroid Carcinoma 03/2005
1	Peptic Ulcer (Peptic Ulcers) 01/2004
1	Necrosis 07/2003
1	Hyperplasia 04/2002
1	Gastroesophageal Reflux (GERD) 04/2002
1	Gallstones (Gallstone) 12/2001
1	Acute Cholecystitis 12/2001
1	Shock 12/2001
1	Colic (Abdominal Cramps) 12/2001
1	Adenocarcinoma 09/2001
1	Prostatic Neoplasms (Prostate Cancer) 09/2001
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2001
1	Liposarcoma 09/2001
1	Colonic Neoplasms (Colon Cancer) 09/2001
1	Hemorrhage 07/2001
1	Pain (Aches) 02/2001
1	Leukopenia 11/2000
1	Tuberculosis (Tuberculoses) 10/2000
1	Dermatitis 08/2000
1	Hypersensitivity (Allergy) 08/2000
1	Pancreatic Ductal Carcinoma 05/2000

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 12/2016 - 09/2001
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2013 - 07/2010
2	Epidermal Growth Factor (EGF)IBA 03/2005 - 04/2002
1	gamma Catenin (Plakoglobin)IBA 01/2018
1	wisteria lectinIBA 12/2016
1	Indicators and Reagents (Reagents)IBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 06/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2013
1	Keratin-5 (Keratin 5)IBA 03/2013
1	Biological ProductsIBA 03/2013
1	human ERBB2 proteinIBA 07/2010
1	Cadherins (E-Cadherin)IBA 07/2010
1	Isoniazid (Ftivazide)FDA LinkGeneric 11/2008
1	Pharmaceutical PreparationsIBA 11/2008
1	tandospironeIBA 06/2005
1	Famotidine (Pepcid)FDA LinkGeneric 06/2005
1	mosaprideIBA 06/2005
1	Tyrosine Kinase InhibitorsIBA 03/2005
1	Gefitinib (Iressa)FDA Link 03/2005
1	ErbB Receptors (EGF Receptor)IBA 03/2005
1	AntigensIBA 08/2004
1	antigen CYFRA21.1IBA 08/2004
1	CarbohydratesIBA 08/2004
1	Carcinoembryonic AntigenIBA 08/2004
1	Therapeutic UsesIBA 08/2004
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2003
1	CytokinesIBA 07/2003
1	GastrinsIBA 07/2003
1	Peroxidase (Myeloperoxidase)IBA 07/2003
1	Cimetidine (Biomet)FDA LinkGeneric 07/2003
1	ChemokinesIBA 07/2003
1	rebamipideIBA 07/2003
1	Colloids (Colloid)IBA 02/2003
1	AcidsIBA 04/2002
1	LigandsIBA 09/2001
1	Messenger RNA (mRNA)IBA 09/2001
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 09/2001
1	PPAR gammaIBA 09/2001
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2001
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2001
1	Immunoglobulin G (IgG)IBA 04/2001
1	Lidocaine (Xylocaine)FDA LinkGeneric 02/2001
1	Saline SolutionIBA 02/2001
1	Codon (Codons)IBA 01/2001
1	DNA (Deoxyribonucleic Acid)IBA 01/2001
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2000
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2000
1	MercuryIBA 08/2000
1	HaptensIBA 08/2000
1	Lansoprazole (Prevacid)FDA LinkGeneric 07/2000
1	Urea (Carbamide)FDA LinkGeneric 07/2000
1	MucinsIBA 05/2000
1	GadoliniumIBA 03/2000

Therapy/Procedure

5	Therapeutics 03/2013 - 11/2000
2	Drug Therapy (Chemotherapy) 01/2019 - 06/2006
1	Neoadjuvant Therapy 06/2016
1	Molecular Targeted Therapy 03/2005
1	Ligation 04/2002
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 12/2001
1	Punctures 07/2001
1	Epidural Injections 02/2001